 Andrew S Lapato
| Title | Post-Doctoral Fellow |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOM-Cell and Devopmental Bio |
|---|
|
|
|
 Research F32NS122997 (LAPATO, ANDREW S)Sep 1, 2021 - Mar 31, 2024 NIH
Impact of pathogenic MS patient-derived IgG on oligodendrocytes: bystanders or participants in remyelination failure?
Role: Principal Investigator |
Bibliographic
-
Lapato AS, Thompson SM, Parra K, Tiwari-Woodruff SK. Astrocyte Glutamate Uptake and Water Homeostasis Are Dysregulated in the Hippocampus of Multiple Sclerosis Patients With Seizures. ASN Neuro. 2020 Jan-Dec; 12:1759091420979604. PMID: 33297722.
-
Karim H, Kim SH, Lauderdale K, Lapato AS, Atkinson K, Yasui N, Yamate-Morgan H, Sekyi M, Katzenellenbogen JA, Tiwari-Woodruff SK. Analogues of ER? ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis. Sci Rep. 2019 01 24; 9(1):503. PMID: 30679747.
-
Karim H, Kim SH, Lapato AS, Yasui N, Katzenellenbogen JA, Tiwari-Woodruff SK. Increase in chemokine CXCL1 by ER? ligand treatment is a key mediator in promoting axon myelination. Proc Natl Acad Sci U S A. 2018 06 12; 115(24):6291-6296. PMID: 29844175.
-
Lapato AS, Tiwari-Woodruff SK. Connexins and pannexins: At the junction of neuro-glial homeostasis & disease. J Neurosci Res. 2018 01; 96(1):31-44. PMID: 28580666.
-
Lapato AS, Szu JI, Hasselmann JPC, Khalaj AJ, Binder DK, Tiwari-Woodruff SK. Chronic demyelination-induced seizures. Neuroscience. 2017 03 27; 346:409-422. PMID: 28153692.
-
Bodhankar S, Chen Y, Lapato A, Dotson AL, Wang J, Vandenbark AA, Saugstad JA, Offner H. PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System Inflammation. Stroke. 2015 Oct; 46(10):2926-34. PMID: 26306753.
-
Bodhankar S, Lapato A, Chen Y, Vandenbark AA, Saugstad JA, Offner H. Role for microglia in sex differences after ischemic stroke: importance of M2. Metab Brain Dis. 2015 Dec; 30(6):1515-29. PMID: 26246072.
-
Zhang J, Benedek G, Bodhankar S, Lapato A, Vandenbark AA, Offner H. IL-10 producing B cells partially restore E2-mediated protection against EAE in PD-L1 deficient mice. J Neuroimmunol. 2015 Aug 15; 285:129-36. PMID: 26198929.
-
Zhang J, Lapato A, Bodhankar S, Vandenbark AA, Offner H. Treatment with IL-10 producing B cells in combination with E2 ameliorates EAE severity and decreases CNS inflammation in B cell-deficient mice. Metab Brain Dis. 2015 Oct; 30(5):1117-27. PMID: 25776868.
-
Zhu W, Dotson AL, Libal NL, Lapato AS, Bodhankar S, Offner H, Alkayed NJ. Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice. Neuroscience. 2015 Mar 12; 288:112-9. PMID: 25556831.
-
Bodhankar S, Chen Y, Lapato A, Vandenbark AA, Murphy SJ, Saugstad JA, Offner H. Regulatory CD8(+)CD122 (+) T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells. Metab Brain Dis. 2015 Aug; 30(4):911-924. PMID: 25537181.
-
Bodhankar S, Chen Y, Lapato A, Vandenbark AA, Murphy SJ, Offner H. Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke. Front Cell Neurosci. 2014; 8:228. PMID: 25157219.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2014 | 3 | | 2015 | 4 | | 2017 | 2 | | 2018 | 1 | | 2019 | 1 | | 2020 | 1 |
To return to the timeline, click here.
|
Lapato's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|